Attention deficit/hyperactivity disorder after neonatal surgery: review of the pathophysiology and risk factors

J J Sistino1

  • 1Division of Cardiovascular Perfusion, College of Health Professions, Medical University of Charleston, Charleston, SC, USA.

Perfusion
|August 21, 2013
PubMed

Insights

Children undergoing neonatal heart surgery have higher rates of attention deficit/hyperactivity disorder (ADHD). This neurological outcome highlights the need for improved cerebral protection strategies during pediatric cardiac surgery to enhance long-term quality of life.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Disorders
  • Pediatric Cardiac Surgery

Background:

  • Long-term neurological deficits are increasingly evident in children surviving complex neonatal heart surgery.
  • Attention deficit/hyperactivity disorder (ADHD) is a significant neurological outcome affecting quality of life for these children and their families.
  • The incidence of ADHD is notably higher in pediatric cardiac surgery survivors compared to the general pediatric population.

Purpose of the Study:

  • To review the pathophysiological basis of ADHD in children following cardiac surgery.
  • To explore the similarities between neonatal cardiac surgical patients and preterm infants regarding ADHD risk.
  • To establish ADHD as a measurable outcome for evaluating cerebral protection strategies and surgical timing in pediatric cardiac surgery.

Main Methods:

  • Literature review focusing on the pathophysiological underpinnings of ADHD.
  • Comparative analysis of risk factors and pathological changes in neonatal cardiac surgery patients and preterm infants.
  • Examination of ADHD incidence as an indicator of neurological outcomes.

Main Results:

  • Neonatal cardiac surgery patients share etiological and pathological similarities with preterm infants, both groups exhibiting increased ADHD risk.
  • The higher incidence of ADHD in this population serves as an indicator of neurological impact from cardiac surgery.
  • ADHD provides a measurable endpoint to assess the efficacy of intraoperative cerebral protection and procedural timing.

Conclusions:

  • Reducing the incidence of ADHD in pediatric cardiac surgery survivors is a critical goal.
  • Developing and evaluating novel cerebral protective strategies should prioritize minimizing long-term neurological deficits like ADHD.
  • Further research into the pathophysiology linking cardiac surgery to ADHD can inform improved patient care and outcomes.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...